|
US20110092677A1
(en)
*
|
2001-08-30 |
2011-04-21 |
Biorexis Technology, Inc. |
Modified transferin-antibody fusion proteins
|
|
US7612112B2
(en)
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
US20030152622A1
(en)
*
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
AU2004204825B2
(en)
|
2003-01-13 |
2007-07-19 |
Dynogen Pharmaceuticals, Inc. |
Method of treating functional bowel disorders
|
|
EP2535042A1
(en)
*
|
2003-06-16 |
2012-12-19 |
ANDRX Pharmaceuticals LLC. |
Oral sustained-release composition comprising a macrolide
|
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
JP2005132803A
(ja)
*
|
2003-10-31 |
2005-05-26 |
Ono Pharmaceut Co Ltd |
胃内滞留固形剤
|
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
AP2006003650A0
(en)
*
|
2003-12-12 |
2006-06-30 |
Penwest Pharmaceuticals Co |
Sustained release torsemide dosage forms
|
|
US20050142187A1
(en)
*
|
2003-12-24 |
2005-06-30 |
Treacy Donald J.Jr. |
Enhanced absorption of modified release dosage forms
|
|
JPWO2005094789A1
(ja)
*
|
2004-03-31 |
2008-02-14 |
Ａｓｐｉｏｎ株式会社 |
Ｓ／ｏ型製剤およびその製造方法
|
|
AU2005249367A1
(en)
*
|
2004-04-16 |
2005-12-15 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and prokinetic agent
|
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
WO2006084164A2
(en)
|
2005-02-01 |
2006-08-10 |
Emisphere Technologies, Inc. |
Gastric retention and controlled release delivery system
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
EP1690540A1
(en)
*
|
2005-02-15 |
2006-08-16 |
Neuro3D |
Composition comprising ocaperidone
|
|
WO2006092064A1
(en)
*
|
2005-03-04 |
2006-09-08 |
Intelgenx Corporation |
Delayed release pharmaceutical oral dosage form and method of making same
|
|
US20080242642A1
(en)
|
2007-04-02 |
2008-10-02 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
|
US9192615B2
(en)
|
2008-08-06 |
2015-11-24 |
Medicis Pharmaceutical Corporation |
Method for the treatment of acne and certain dosage forms thereof
|
|
US8722650B1
(en)
|
2005-06-24 |
2014-05-13 |
Medicis Pharmaceutical Corporation |
Extended-release minocycline dosage forms
|
|
US8252776B2
(en)
*
|
2007-04-02 |
2012-08-28 |
Medicis Pharmaceutical Corporation |
Minocycline oral dosage forms for the treatment of acne
|
|
US7919483B2
(en)
*
|
2005-06-24 |
2011-04-05 |
Medicis Pharmaceutical Corporation |
Method for the treatment of acne
|
|
PT1919466E
(pt)
|
2005-07-11 |
2012-05-21 |
Cortria Corp |
Formulações para tratamento de anormalidades de lipoproteína compreendendo uma estatina e um derivado de metilnicotinamida
|
|
US8497258B2
(en)
|
2005-11-12 |
2013-07-30 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
US20090176882A1
(en)
*
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
PE20080907A1
(es)
*
|
2006-08-31 |
2008-08-22 |
Novartis Ag |
Sistema de suministro de farmaco oral gastro-retentivo de liberacion extendida para valsartan
|
|
WO2008030830A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Drugtech Corporation |
Sustained-release composition and method of use thereof
|
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
GB0707127D0
(en)
*
|
2007-04-13 |
2007-05-23 |
Zysis Ltd |
Pharmaceutical compositions
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
|
TW200914006A
(en)
*
|
2007-07-12 |
2009-04-01 |
Takeda Pharmaceutical |
Coated preparation
|
|
EP2192892A2
(en)
*
|
2007-07-27 |
2010-06-09 |
Depomed, Inc. |
Pulsatile gastric retentive dosage forms
|
|
HRP20180408T1
(hr)
*
|
2007-11-13 |
2018-04-20 |
Meritage Pharma, Inc. |
Pripravci za liječenje gastrointestinalnih upala
|
|
US20090143343A1
(en)
|
2007-11-13 |
2009-06-04 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
|
EP2249811A1
(en)
|
2008-01-25 |
2010-11-17 |
Grünenthal GmbH |
Pharmaceutical dosage form
|
|
US8372432B2
(en)
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
|
KR101690094B1
(ko)
|
2008-05-09 |
2016-12-27 |
그뤼넨탈 게엠베하 |
분무 응결 단계의 사용하에 중간 분말 제형 및 최종 고체 제형을 제조하는 방법
|
|
CA2930674A1
(en)
|
2008-06-04 |
2009-12-10 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
JP2011528375A
(ja)
|
2008-07-16 |
2011-11-17 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
|
ES2740360T3
(es)
|
2008-08-15 |
2020-02-05 |
Assertio Therapeutics Inc |
Composiciones farmacéuticas de retención gástrica para el tratamiento y la prevención de trastornos del SNC
|
|
BRPI0914080A2
(pt)
|
2008-10-08 |
2015-10-27 |
Bioplus Life Sciences Pvt Ltda |
"sistema de liberação de dosagem controlada, método de administração e processo de preparação do mesmo"
|
|
US8822610B2
(en)
|
2008-12-22 |
2014-09-02 |
ATRP Solutions, Inc. |
Control over controlled radical polymerization processes
|
|
US8815971B2
(en)
|
2008-12-22 |
2014-08-26 |
ATRP Solutions, Inc. |
Control over controlled radical polymerization processes
|
|
EP2210585A1
(en)
|
2009-01-16 |
2010-07-28 |
Exelgyn |
SPRM pharmaceutical compositions methods of treatment using them
|
|
WO2010123574A1
(en)
|
2009-04-23 |
2010-10-28 |
Atrp Solutions Inc |
Star macromolecules for personal and home care
|
|
US9783628B2
(en)
|
2009-04-23 |
2017-10-10 |
ATRP Solutions, Inc. |
Dual-mechanism thickening agents for hydraulic fracturing fluids
|
|
US8173750B2
(en)
|
2009-04-23 |
2012-05-08 |
ATRP Solutions, Inc. |
Star macromolecules for personal and home care
|
|
WO2010129686A1
(en)
|
2009-05-05 |
2010-11-11 |
Vapogenix, Inc. |
Novel formulations of volatile anesthetics and methods of use for reducing inflammation
|
|
AR077493A1
(es)
|
2009-07-22 |
2011-08-31 |
Gruenenthal Gmbh |
Composicion farmaceutica extruida en caliente con liberacion controlada. procedimiento de preparacion
|
|
SI2456424T1
(sl)
|
2009-07-22 |
2013-10-30 |
Gruenenthal Gmbh |
Oksidacijsko stabilizirana odmerna oblika, varna pred zlorabo
|
|
AU2010278894B2
(en)
|
2009-07-30 |
2014-01-30 |
Tandem Diabetes Care, Inc. |
Infusion pump system with disposable cartridge having pressure venting and pressure feedback
|
|
FR2949061B1
(fr)
*
|
2009-08-12 |
2013-04-19 |
Debregeas Et Associes Pharma |
Microgranules flottants
|
|
WO2011027346A1
(en)
*
|
2009-09-03 |
2011-03-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A gastroretentive dosage form for oral treatment of domestic animals
|
|
US8901113B2
(en)
|
2009-09-30 |
2014-12-02 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
|
US8597681B2
(en)
|
2009-12-22 |
2013-12-03 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
|
US9198861B2
(en)
|
2009-12-22 |
2015-12-01 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
|
US20110150989A1
(en)
*
|
2009-12-22 |
2011-06-23 |
Mallinkckrodt Inc. |
Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
|
|
EP2531176B1
(en)
|
2010-02-03 |
2016-09-07 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
|
CN103347517B
(zh)
|
2010-08-11 |
2018-10-02 |
德雷克塞尔大学 |
治疗帕金森病中运动障碍的d3多巴胺受体激动剂
|
|
MX2013002377A
(es)
|
2010-09-02 |
2013-04-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
|
|
PL2611425T3
(pl)
|
2010-09-02 |
2014-09-30 |
Gruenenthal Gmbh |
Odporna na ingerencję postać dawki zawierająca polimer anionowy
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
JP6076913B2
(ja)
|
2010-12-07 |
2017-02-08 |
ドレクセル ユニバーシティ |
癌からの転移を阻害する方法
|
|
US9587064B2
(en)
|
2010-12-08 |
2017-03-07 |
ATRP Solutions, Inc. |
Salt-tolerant star macromolecules
|
|
US8476221B2
(en)
|
2011-03-18 |
2013-07-02 |
Halimed Pharmaceuticals, Inc. |
Methods and compositions for the treatment of metabolic disorders
|
|
US8858963B1
(en)
|
2011-05-17 |
2014-10-14 |
Mallinckrodt Llc |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
|
US8741885B1
(en)
|
2011-05-17 |
2014-06-03 |
Mallinckrodt Llc |
Gastric retentive extended release pharmaceutical compositions
|
|
US9050335B1
(en)
|
2011-05-17 |
2015-06-09 |
Mallinckrodt Llc |
Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
|
|
US9119793B1
(en)
|
2011-06-28 |
2015-09-01 |
Medicis Pharmaceutical Corporation |
Gastroretentive dosage forms for doxycycline
|
|
US9561241B1
(en)
|
2011-06-28 |
2017-02-07 |
Medicis Pharmaceutical Corporation |
Gastroretentive dosage forms for minocycline
|
|
JP2014524925A
(ja)
|
2011-07-29 |
2014-09-25 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
即時薬剤放出を提供するタンパーレジスタント錠剤
|
|
EP2736497B1
(en)
|
2011-07-29 |
2017-08-23 |
Grünenthal GmbH |
Tamper-resistant tablet providing immediate drug release
|
|
US20130143867A1
(en)
|
2011-12-02 |
2013-06-06 |
Sychroneuron Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
|
KR20190007106A
(ko)
|
2011-12-21 |
2019-01-21 |
노비라 테라퓨틱스, 인코포레이티드 |
B형 간염의 항바이러스성 제제
|
|
MX356421B
(es)
|
2012-02-28 |
2018-05-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
|
|
CN102579344B
(zh)
*
|
2012-03-02 |
2014-02-26 |
海南美兰史克制药有限公司 |
氯沙坦钾脂质体固体制剂
|
|
AR090695A1
(es)
|
2012-04-18 |
2014-12-03 |
Gruenenthal Gmbh |
Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
|
PL2872121T3
(pl)
|
2012-07-12 |
2019-02-28 |
SpecGx LLC |
Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania
|
|
WO2014015157A2
(en)
|
2012-07-19 |
2014-01-23 |
Philadelphia Health & Education Corporation |
Novel sigma receptor ligands and methods of modulating cellular protein homeostasis using same
|
|
EP3378472A1
(en)
|
2012-08-09 |
2018-09-26 |
Dynamis Therapeutics, Inc. |
Combinations of meglumine
|
|
EP2890760A4
(en)
|
2012-08-30 |
2016-10-12 |
Atrp Solutions Inc |
DOUBLE MECHANISM THICKENERS FOR HYDRAULIC FRACKING FLUIDS
|
|
US9550780B2
(en)
|
2012-09-18 |
2017-01-24 |
Auspex Pharmaceuticals, Inc. |
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
|
|
CA2883641C
(en)
|
2012-09-18 |
2021-09-14 |
Auspex Pharmaceuticals, Inc. |
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
|
|
RU2018141241A
(ru)
|
2012-11-30 |
2019-01-24 |
Экьюра Фармасьютикалз, Инк. |
Саморегулируемое высвобождение фармацевтического ингредиента
|
|
WO2014100077A1
(en)
*
|
2012-12-21 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
Gastro-retentive formulations
|
|
PT2941233T
(pt)
|
2013-01-07 |
2020-11-13 |
Univ Pennsylvania |
Composições e métodos para tratar linfoma cutâneo de células t
|
|
CA2899349C
(en)
|
2013-02-04 |
2021-09-21 |
ATRP Solutions, Inc. |
Salt-tolerant star macromolecules
|
|
EP3718557A3
(en)
|
2013-02-25 |
2020-10-21 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
|
|
US10201656B2
(en)
|
2013-03-13 |
2019-02-12 |
Tandem Diabetes Care, Inc. |
Simplified insulin pump for type II diabetics
|
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
|
US10842802B2
(en)
|
2013-03-15 |
2020-11-24 |
Medicis Pharmaceutical Corporation |
Controlled release pharmaceutical dosage forms
|
|
CA2905435A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
US9492608B2
(en)
|
2013-03-15 |
2016-11-15 |
Tandem Diabetes Care, Inc. |
Method and device utilizing insulin delivery protocols
|
|
US9737490B2
(en)
|
2013-05-29 |
2017-08-22 |
Grünenthal GmbH |
Tamper resistant dosage form with bimodal release profile
|
|
MX371432B
(es)
|
2013-05-29 |
2020-01-30 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
|
|
CA2914365C
(en)
|
2013-06-05 |
2022-03-15 |
Synchroneuron, Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
|
EP3613861A1
(en)
|
2013-07-02 |
2020-02-26 |
EcoPlanet Environmental LLC |
Volatile organic compound formulations having antimicrobial activity
|
|
GB201311888D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
GB201311891D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compound
|
|
EA032465B1
(ru)
|
2013-07-12 |
2019-05-31 |
Грюненталь Гмбх |
Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления
|
|
MY176976A
(en)
|
2013-10-10 |
2020-08-28 |
Bausch Health Ireland Ltd |
Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions
|
|
BR112016010482B1
(pt)
|
2013-11-26 |
2022-11-16 |
Grünenthal GmbH |
Preparação de uma composição farmacêutica em pó por meio de criomoagem
|
|
JP6932506B2
(ja)
|
2013-11-26 |
2021-09-08 |
イエール ユニバーシティ |
細胞透過組成物およびそれを用いる方法
|
|
CN105873589B
(zh)
|
2013-12-03 |
2019-11-01 |
奥斯拜客斯制药有限公司 |
制造苯并喹啉化合物的方法
|
|
EP3079692A4
(en)
|
2013-12-09 |
2017-10-18 |
Thomas Jefferson University |
Novel methods of treating a neurodegenerative disease in a mammal in need thereof
|
|
WO2015157262A1
(en)
|
2014-04-07 |
2015-10-15 |
Women & Infants Hospital Of Rhode Island |
Novel 7-Dehydrocholesterol Derivatives and Methods Using Same
|
|
US20180228907A1
(en)
|
2014-04-14 |
2018-08-16 |
Arvinas, Inc. |
Cereblon ligands and bifunctional compounds comprising the same
|
|
MX2016014738A
(es)
|
2014-05-12 |
2017-03-06 |
Gruenenthal Gmbh |
Formulacion en capsula de liberacion inmediata resistente a alteraciones que comprende tapentadol.
|
|
MX2016015417A
(es)
|
2014-05-26 |
2017-02-22 |
Gruenenthal Gmbh |
Multiparticulas protegidas contra vertido de dosis etanolico.
|
|
RU2016151697A
(ru)
|
2014-06-02 |
2018-07-10 |
Тева Фармасьютикал Индастриз Лтд. |
Расправляемая удерживаемая в желудке лекарственная форма
|
|
CN106573015B
(zh)
*
|
2014-06-11 |
2021-11-26 |
麻省理工学院 |
肠溶弹性体
|
|
MX385886B
(es)
|
2014-07-03 |
2025-03-18 |
Pilot Polymer Tech Inc |
Macromoleculas estrellas compatibles con tensoactivos.
|
|
CN106714809A
(zh)
|
2014-08-20 |
2017-05-24 |
耶鲁大学 |
对治疗或预防肝脏疾病或障碍和促进体重减轻有用的新型组合物和方法
|
|
JP6932641B2
(ja)
|
2015-03-06 |
2021-09-08 |
オースペックス ファーマシューティカルズ インコーポレイテッド |
異常不随意運動障害の処置のための方法
|
|
EA035434B1
(ru)
|
2015-04-24 |
2020-06-15 |
Грюненталь Гмбх |
Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
|
|
WO2016182968A1
(en)
|
2015-05-08 |
2016-11-17 |
Brown University |
Novel syringolin analogues and methods of making and using same
|
|
JP6995627B2
(ja)
|
2015-05-19 |
2022-02-04 |
イエール ユニバーシティ |
病的石灰化状態を治療するための組成物およびそれを使用する方法
|
|
KR20180014778A
(ko)
|
2015-06-03 |
2018-02-09 |
트리아스텍 인코포레이티드 |
제형 및 이의 용도
|
|
WO2016201288A1
(en)
|
2015-06-12 |
2016-12-15 |
Brown University |
Novel antibacterial compounds and methods of making and using same
|
|
KR102207539B1
(ko)
|
2015-06-30 |
2021-01-26 |
네우라드 리미티드 |
신규한 호흡 제어 조절 화합물, 및 그의 제조 및 사용 방법
|
|
CN108135835A
(zh)
|
2015-08-06 |
2018-06-08 |
约翰霍普金斯大学 |
用于治疗代谢紊乱的组合物和方法
|
|
WO2017040607A1
(en)
|
2015-08-31 |
2017-03-09 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for self-regulated release of active pharmaceutical ingredient
|
|
WO2017042325A1
(en)
|
2015-09-10 |
2017-03-16 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
|
WO2017075145A1
(en)
|
2015-10-28 |
2017-05-04 |
Yale University |
Quinoline amides and methods of using same
|
|
JP2018537093A
(ja)
|
2015-11-20 |
2018-12-20 |
イエール ユニバーシティ |
異所性石灰化障害を治療するための組成物およびそれを使用する方法
|
|
EP3402804A1
(en)
|
2016-01-11 |
2018-11-21 |
Synergy Pharmaceuticals Inc. |
Formulations and methods for treating ulcerative colitis
|
|
EP3448369B1
(en)
|
2016-04-29 |
2025-06-25 |
The Regents of The University of Colorado, A Body Corporate |
Inhibition or degradation of hdac11 for treating obesity, hyperlipidemia, type ii diabetes, metabolic syndrome or insulin resistance, for promoting weight loss, and/or ameliorating or preventing weight gain
|
|
US20210330599A1
(en)
|
2016-08-01 |
2021-10-28 |
University Of Rochester |
Nanoparticles for Controlled Release of Anti-Biofilm Agents and Methods of Use
|
|
US11390859B2
(en)
|
2016-08-05 |
2022-07-19 |
Yale University |
Compositions and methods for stroke prevention in pediatric sickle cell anemia patients
|
|
AU2017321791B2
(en)
|
2016-09-01 |
2022-03-24 |
Mebias Discovery, Inc. |
Substituted ureas and methods of making and using same
|
|
AU2017353986B2
(en)
|
2016-11-07 |
2021-08-19 |
Arbutus Biopharma Corporation |
Substituted pyridinone-containing tricyclic compounds, and methods using same
|
|
US10737079B2
(en)
|
2016-12-02 |
2020-08-11 |
Clexio Biosciences Ltd. |
Gastric residence system
|
|
US10941126B2
(en)
|
2017-01-19 |
2021-03-09 |
Temple University-Of The Commonwealth System Of Higher Education |
Bridged bicycloalkyl-substituted aminothiazoles and their methods of use
|
|
EP3601216B1
(en)
|
2017-03-21 |
2023-10-25 |
Arbutus Biopharma Corporation |
Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same for the treatment of hepatitis b virus infection
|
|
US11166953B2
(en)
|
2017-04-17 |
2021-11-09 |
Yale University |
Compounds, compositions and methods of treating or preventing acute lung injury
|
|
US10588863B2
(en)
|
2017-06-16 |
2020-03-17 |
Kashiv Biosciences, Llc |
Extended release compositions comprising pyridostigmine
|
|
US10987311B2
(en)
|
2017-06-16 |
2021-04-27 |
Kashiv Specialty Pharmaceuticals, Llc |
Extended release compositions comprising pyridostigmine
|
|
ES2928071T3
(es)
|
2017-06-16 |
2022-11-15 |
Amneal Complex Products Res Llc |
Formas de dosificación gastrorretentiva para el suministro sostenido de fármacos
|
|
WO2019023621A1
(en)
|
2017-07-28 |
2019-01-31 |
Yale University |
ANTICANCER DRUGS AND METHODS OF MAKING AND USING THEM
|
|
KR20200072478A
(ko)
|
2017-09-08 |
2020-06-22 |
더 리전츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코퍼레이트 |
Her-구동된 약물-내성암의 치료 또는 예방을 위한 화합물, 조성물 및 방법
|
|
CN111655230A
(zh)
*
|
2017-11-07 |
2020-09-11 |
拉尼医疗有限公司 |
使用可吞服药物递送装置递送到肠道组织中的凝血因子制剂
|
|
EP3716985A1
(en)
|
2017-11-27 |
2020-10-07 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Compounds, compositions, and methods for treating and/or preventing periodontal disease
|
|
US11547839B2
(en)
|
2017-12-04 |
2023-01-10 |
Clexio Biosciences Ltd. |
Long acting gastric residence system
|
|
IL275444B2
(en)
|
2017-12-18 |
2025-01-01 |
Tris Pharma Inc |
Modified release drug powder formulation containing gastric-retaining raft-forming systems with pulsed drug release
|
|
WO2019126214A1
(en)
|
2017-12-18 |
2019-06-27 |
Tris Pharma, Inc. |
Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
|
|
WO2019126215A1
(en)
|
2017-12-18 |
2019-06-27 |
Tris Pharma, Inc. |
Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
|
|
WO2019125184A1
(en)
|
2017-12-19 |
2019-06-27 |
Auckland Uniservices Limited |
Use of biomarker in cancer therapy
|
|
WO2019126125A1
(en)
|
2017-12-20 |
2019-06-27 |
Purdue Pharma L.P. |
Abuse deterrent morphine sulfate dosage forms
|
|
EP3743060A4
(en)
|
2018-01-24 |
2021-11-03 |
The Rockefeller University |
ANTIBACTERIAL COMPOUNDS, RELATED COMPOSITIONS AND THEIR METHODS OF USE
|
|
KR20200116110A
(ko)
|
2018-01-29 |
2020-10-08 |
듀크 유니버시티 |
5-히드록시트립토판 생체이용률을 높이는 조성물 및 방법
|
|
BR112020024048A2
(pt)
|
2018-05-25 |
2021-02-17 |
Temple University-Of The Commonwealth System Of Higher Education |
composição, e, métodos para descolonizar um organismo microbiano, para destruir ou interromper ou inibir ou reduzir a formação de biofilme de um organismo microbiano e para tratar uma infecção microbiana em um indivíduo.
|
|
US11091473B2
(en)
|
2018-05-29 |
2021-08-17 |
Acadia Pharmaceuticals Inc. |
Compounds for pain treatment, compositions comprising same, and methods of using same
|
|
EP4056172A1
(en)
|
2018-06-18 |
2022-09-14 |
Amneal Complex Products Research LLC |
Extended release compositions comprising pyridostigmine
|
|
TWI826492B
(zh)
|
2018-07-27 |
2023-12-21 |
加拿大商愛彼特生物製藥公司 |
經取代四氫環戊[c]吡咯、經取代二氫吡咯，其類似物及使用其之方法
|
|
MX2021001877A
(es)
|
2018-08-17 |
2021-07-15 |
Univ Pennsylvania |
Composiciones y métodos para el tratamiento de lesión pulmonar aguda.
|
|
WO2020074944A1
(en)
|
2018-10-11 |
2020-04-16 |
Sanifit Therapeutics S.A. |
Inositol phosphates for the treatment of ectopic calcification
|
|
WO2020081762A1
(en)
|
2018-10-19 |
2020-04-23 |
Temple University-Of The Commonwealth System Of Higher Education |
Tamper-resistant drug dosage forms and methods of making and use thereof
|
|
TW202415643A
(zh)
|
2018-12-12 |
2024-04-16 |
加拿大商愛彼特生物製藥公司 |
經取代之芳基甲基脲類及雜芳基甲基脲類、其類似物及其使用方法
|
|
KR20210148078A
(ko)
|
2019-01-30 |
2021-12-07 |
사니핏 테라퓨틱스 에스.에이. |
조직 관류 증가에 사용하기 위한 이노시톨 포스페이트 화합물
|
|
US20200246316A1
(en)
|
2019-02-01 |
2020-08-06 |
Cersci Therapeutics, Inc. |
Methods of treating post-surgical pain with a thiazoline anti-hyperalgesic agent
|
|
US20200246317A1
(en)
|
2019-02-01 |
2020-08-06 |
Cersci Therapeutics, Inc. |
Methods of treating diabetic neuropathy with a thiazoline anti-hyperalgesic agent
|
|
WO2020227603A1
(en)
|
2019-05-09 |
2020-11-12 |
The Feinstein Institutes For Medical Research |
Hmgb1 antagonist
|
|
JP2022538767A
(ja)
|
2019-06-12 |
2022-09-06 |
ザ ウィスター インスティテュート |
アセチルＣｏＡシンテターゼ２（ＡＣＳＳ２）阻害剤およびそれを使用する方法
|
|
US11555010B2
(en)
|
2019-07-25 |
2023-01-17 |
Brown University |
Diamide antimicrobial agents
|
|
EP3818983A1
(en)
|
2019-11-11 |
2021-05-12 |
Sanifit Therapeutics S.A. |
Inositol phosphate compounds for use in treating, inhibiting the progression, or preventing cardiovascular calcification
|
|
WO2021127456A1
(en)
|
2019-12-19 |
2021-06-24 |
Rain Therapeutics Inc. |
Methods of inhibiting epidermal growth factor receptor proteins
|
|
BR112022024958A2
(pt)
|
2020-06-09 |
2022-12-27 |
Inozyme Pharma Inc |
Proteínas enpp1 solúveis e usos das mesmas
|
|
EP4236924A4
(en)
*
|
2020-10-30 |
2024-10-09 |
Triastek, Inc. |
DOSAGE FORMS OF MEDICATION TO BE RETAINED IN THE STOMACH
|
|
EP4015494A1
(en)
|
2020-12-15 |
2022-06-22 |
Sanifit Therapeutics S.A. |
Processes for the preparation of soluble salts of inositol phosphates
|
|
EP4036097A1
(en)
|
2021-01-29 |
2022-08-03 |
Sanifit Therapeutics S.A. |
Ip4-4,6 substituted derivative compounds
|
|
MX2024001390A
(es)
|
2021-07-30 |
2024-05-17 |
Evecxia Therapeutics Inc |
Formas de dosificacion gastrorretentivas de 5-hidroxitriptofano.
|
|
US12409163B2
(en)
|
2021-07-30 |
2025-09-09 |
Evecxia Therapeutics, Inc. |
Method of enhancing 5-hydroxytryptophan (5-HTP) exposure
|
|
WO2023064598A1
(en)
|
2021-10-14 |
2023-04-20 |
Evecxia Therapeutics, Inc. |
A method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposes
|
|
JP2025525092A
(ja)
|
2022-07-29 |
2025-08-01 |
サニフィット・セラピューティクス・ソシエダッド・アノニマ |
異所性石灰化の治療、進行の阻害、および予防に使用するためのｉｐ４－４，６置換誘導体化合物
|
|
TW202412815A
(zh)
|
2022-07-29 |
2024-04-01 |
西班牙商薩尼菲特治療公司 |
Ip5經取代化合物
|
|
CN115184371B
(zh)
*
|
2022-08-05 |
2023-04-25 |
深圳市俱进纸品包装有限公司 |
一种礼盒印刷的瑕疵视觉检测装置
|
|
KR20250059489A
(ko)
|
2022-09-06 |
2025-05-02 |
하다지트 메디칼 리서치 써비시즈 앤드 디벨롭먼트 리미티드 |
조현병 및 기타 신경정신장애 및 신경학적 장애의 치료를 위한 환각물질 포함 조합물
|
|
KR20240108663A
(ko)
*
|
2023-01-02 |
2024-07-09 |
일양약품주식회사 |
베타네콜을 함유하는 안정한 방출 제어형 약제학적 조성물 및 이의 제조방법
|
|
TW202513071A
(zh)
|
2023-08-14 |
2025-04-01 |
以色列商琉璃藥品 (1991) 有限公司 |
Gal475組合物及其使用方法
|
|
WO2025162971A1
(en)
|
2024-01-31 |
2025-08-07 |
Sanifit Therapeutics, S.A. |
Substituted ip5 compounds for use in the treatment, inhibition of progression, and prevention of ectopic calcification
|
|
WO2025217096A1
(en)
|
2024-04-08 |
2025-10-16 |
University Of Rochester |
Inhibitors of leucine-rich repeat kinase 2 (lrrk2) and medical uses thereof
|
|
WO2025217094A1
(en)
|
2024-04-08 |
2025-10-16 |
University Of Rochester |
Interleukin receptor-associated kinase (irak) protac degraders and medical use thereof
|
|
WO2025217379A1
(en)
|
2024-04-10 |
2025-10-16 |
University Of Rochester |
Drug treatment for macular degeneration
|